Daniel Keizman

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma

Daniel Keizman, Maya Ish‐Shalom, Peng Huang et al. · European Journal of Cancer · 2011 · 213 citations

Medicine, Oncology, Pharmacology +12

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

Arlene O. Siefker‐Radtke, Andrea Necchi, Se Hoon Park et al. · The Lancet Oncology · 2022 · 169 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?

Daniel Keizman, Maya Ish‐Shalom, Shlomo Berliner et al. · Journal of the Neurological Sciences · 2009 · 139 citations

Life Sciences, Biochemistry, Neurology +7

Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination

Daniel Keizman, Peng Huang, Mario A. Eisenberger et al. · European Journal of Cancer · 2011 · 128 citations

Medicine, Oncology, Pharmacology +15

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

Silke Gillessen, Fabio Turco, Ian D. Davis et al. · European Urology · 2024 · 115 citations · Full text

Medicine, Oncology, Urology +9